WHC is still in active development. Read this to understand our approach.
depiction of ACGDKVXYNVEAGU-UHFFFAOYSA-N.svg
isomerdesign

Guanethidine

Verificar en isomerdesign

pubchem

Guanethidine

Verificar en pubchem

drugmap

Guanethidine

Verificar en drugmap

Data

InChI: InChI=1S/C10H22N4/c11-10(12)13-6-9-14-7-4-2-1-3-5-8-14/h1-9H2,(H4,11,12,13)

Sinónimos: Sanotensin, Ismelin sulfate,SCHEMBL34753,ZTI6C33Q2Q, Guanethidine (INN), Octadine,CHEMBL765,Oktatensin,AB00053479_05,Ismelin, (2-(Octahydro-1-azocinyl)ethyl)guanidine,SPBio_002533,SU 5864 (Salt/Mix), 2-(1'-Azacyclooctyl)ethylguanidine,Iporal (Salt/Mix),guanethidine sulfate,2-(2-(azocan-1-yl)ethyl)guanidine, Guanethidine sulfate,Guanetidina [INN-Spanish],CHEBI:5557, Guanetidina [INN-Spanish],Octadin,55-65-2,KBio2_003885,2-(1'-Azacyclooctyl)ethylguanidine,GUANETHIDINE [HSDB],HY-B1251, Octatensin,Heptamethylenimine, 1-(2-guanidinoethyl)-, Oktadin,2-[2-(azocan-1-yl)ethyl]guanidine,1-(2-azocan-1-ylethyl)guanidine,BSPBio_000314, Su 5864 sulfate (1:1),(2-(Octahydro-1-azocinyl)ethyl)guanidine, Guanetidina,NCGC00016272-03,DB01170, 1-[2-(azocan-1-yl)ethyl]guanidine,EINECS 200-241-3,Prestwick2_000317,Guanetidina,NCGC00016272-01,(2-(hexahydro-1(2h)-azocinyl)ethyl)guanidine,Guanethidine (INN), Apo-Guanethidine (TN),CS-0013044,Sanotensin,NCGC00016272-02,Dopam,BPBio1_000346,Guanidine, [2-(hexahydro-1(2H)-azocinyl)ethyl]-,STK895063,Spectrum3_000446,Guanethidine [INN:BAN],GUANETHIDINE,3h-guanethidine, Beta-1-Azacyclooctylethylguanidine,AB00053479_04,Spectrum_000837,CAS-60-02-6,N-(2-Perhydroazocin-1-ylethyl)guanidine,UNII-ZTI6C33Q2Q,L000732,Oktadin,Spectrum2_001103,STR07524,Octadine,CCG-213488, Guanethidinum [INN-Latin], Ismelin, 1-(2-azocan-1-ylethyl)guanidine,Azocine, 1-[[2-(aminoiminomethyl)amino]ethyl]octahydro-, N-(2-Perhydroazocin-1-ylethyl)guanidine,Octatensine,Spectrum5_000784,SPBio_001206,Iporal,GUANETHIDINE [VANDF],Z1198152903, Guanethidine Sulfate (1:1), Octatensine, Apo-Guanethidine,[2-(Hexahydro-1(2H)-azocinyl)ethyl]guanidine,NSC29863,Prestwick3_000317,C07036,Octatenzine,2-(1-N,N-Heptamethyleneimino)ethylguanidine,Eutensol,[2-(Octahydro-1-azocinyl)ethyl]guanidine,Isobarin (Salt/Mix),HSDB 3092, Isobarin,DivK1c_000539, Guanethidine Sulfate (2:1),KBioGR_000976, 2-(1-N,N-Heptamethyleneimino)ethylguanidine, Dopom,NCGC00247765-01,NINDS_000539,.Beta.-1-Azacyclooctylethylguanidine, Octadin,GUANETHIDINE [WHO-DD],N''-[2-(azocan-1-yl)ethyl]guanidine,Isobarin,IDI1_000539,SBI-0051399.P003,Guanethidinum [INN-Latin],KBio2_001317,AKOS005614041,Azocine, 1-(2-guanidinoethyl)octahydro-,Azocine, 1-((2-(aminoiminomethyl)amino)ethyl)octahydro-,N-[2-(azocan-1-yl)ethyl]guanidine,AB00053479,Octatensin,Guanethidinum,GUANETHIDINE [MI],Guanetidin sulfate,D08030,Su 5864 sulfate (1:1),Dopom, Dopam,Guanidine, N-[2-(hexahydro-1(2H)-azocinyl)ethyl]-,Oktatenzin,Spectrum4_000568, ((2-Hexahydro-1(2H)-azocinyl)ethyl)guanidine,KBio2_006453,DTXSID5023116, Oktatensin,Guanidine, (2-(hexahydro-1(2H)-azocinyl)ethyl)-,KBio3_001312, Eutensol, 2-[2-(azocan-1-yl)ethyl]guanidine,Guanethidine,GUANETHIDINE [INN],Prestwick1_000317, Guanethidinum,Abapresin,1-(2-(Azocan-1-yl)ethyl)guanidine,KBioSS_001317, Guanethidine Sulphae,BSPBio_002092,ZINC1530648,Q420673,1-[2-(azocan-1-yl)ethyl]guanidine,N-[2-(1-Azocanyl)ethyl]guanidine #,EN300-123310,Prestwick0_000317, Oktatenzin,KBio1_000539, Guanethidine [INN:BAN],GTPL7194

Estimated data

Solubilidad: -0.545 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 60.5% (prediction based on www.mdpi.com)

Similitudes

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.